SCHEMBL17523932

SCHEMBL17523932

CCN(CC)CCCCC[C@H](O)CCCC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.42
ACACA Q13085 1/20 0.42
SIGMAR1 Q99720 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.37
PLA2G1B P04054 1/20 0.35
PLA2G2A P14555 1/20 0.35
FFAR4 Q5NUL3 1/20 0.34
FFAR1 O14842 1/20 0.34
GPR84 Q9NQS5 5/20 0.33
PAOX Q6QHF9 1/20 0.31
RIPK1 Q13546 1/20 0.31
CACNA1F O60840 1/20 0.31
CHRM2 P08172 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
CHRM3 P20309 1/20 0.31
HTR2A P28223 1/20 0.31
SLC6A4 P31645 1/20 0.31
DRD3 P35462 1/20 0.31
CACNA1D Q01668 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17523929 1.00 ACACB (0.42) ACACBACACASIGMAR1L3MBTL1PLA2G1B
SCHEMBL17523852 0.98 SIGMAR1 (0.42) ACACBACACASIGMAR1L3MBTL1PLA2G1B
SCHEMBL17523853 0.98 SIGMAR1 (0.42) ACACBACACASIGMAR1L3MBTL1PLA2G1B
SCHEMBL17523801 0.92 ACACB (0.36) ACACBACACASIGMAR1L3MBTL1RIPK1
SCHEMBL17523800 0.92 ACACB (0.36) ACACBACACASIGMAR1L3MBTL1RIPK1
SCHEMBL1147629 0.86 SIGMAR1 (0.50) ACACBACACASIGMAR1L3MBTL1PLA2G1B
SCHEMBL17526514 0.82 PLA2G1B (0.47) SIGMAR1L3MBTL1PLA2G1BPLA2G2AFFAR4
SCHEMBL17526657 0.82 PLA2G1B (0.47) SIGMAR1L3MBTL1PLA2G1BPLA2G2AFFAR4
SCHEMBL21016075 0.82 SIGMAR1 (0.44) SIGMAR1PAOXSLC6A4KCNH2CACNA2D1
SCHEMBL17523776 0.82 SIGMAR1 (0.44) SIGMAR1PAOXSLC6A4KCNH2CACNA2D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. (US) 2016-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 ACACB 1771/4885ACACA 2462/4885SIGMAR1 3999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.